-
EP4527417
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4527417
| EP4527417 - ANTI-TUMOR AGENT CONTAINING RNA, AND USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 21.02.2025 Database last updated on 24.03.2026 | |
| Former | The international publication has been made Status updated on 24.11.2023 | Most recent event Tooltip | 18.07.2025 | Change: Validation states | published on 20.08.2025 [2025/34] | 18.07.2025 | Change - extension states | published on 20.08.2025 [2025/34] | Applicant(s) | For all designated states GF Mille Co. Ltd. 1-1, Yanagido Gifu-shi, Gifu 501-1193 / JP | For all designated states Shinshu University 1-1, Asahi 3-chome Matsumoto-shi, Nagano 390-8621 / JP | For all designated states NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM 1, Furo-cho Chikusa-ku Nagoya-shi, Aichi 464-8601 / JP | [2025/13] | Inventor(s) | 01 /
HIRATSUKA Sachie Matsumoto-shi, Nagano 390-8621 / JP | 02 /
TOMITA Takeshi Matsumoto-shi, Nagano 390-8621 / JP | 03 /
HAYASHI Hikaru Matsumoto-shi, Nagano 390-8621 / JP | 04 /
UENO Yoshihito Gifu-shi, Gifu 501-1193 / JP | 05 /
CHANO Tokuhiro Gifu-shi, Gifu 501-1193 / JP | 06 /
FURUICHI Yasuhiro Gifu-shi, Gifu 501-1193 / JP | 07 /
KAWADE Miwa Gifu-shi, Gifu 501-1193 / JP | 08 /
KAKIZAWA Yuri Gifu-shi, Gifu 501-1193 / JP | [2025/13] | Representative(s) | Leonard, Thomas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2025/13] | Application number, filing date | 23807681.4 | 17.05.2023 | [2025/13] | WO2023JP18498 | Priority number, date | JP20220081120 | 17.05.2022 Original published format: JP 2022081120 | [2025/13] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023224080 | Date: | 23.11.2023 | Language: | JA | [2023/47] | Type: | A1 Application with search report | No.: | EP4527417 | Date: | 26.03.2025 | Language: | EN | [2025/13] | Search report(s) | International search report - published on: | JP | 23.11.2023 | Classification | IPC: | A61K48/00, A61P35/00, A61P35/04, A61P37/04, C12N15/11, A61K31/7088, A61K31/712 | [2025/13] | CPC: |
A61P35/00 (EP,KR);
A61K31/7088 (KR);
A61K31/712 (EP,KR);
A61K48/005 (EP,KR);
A61P35/04 (EP,KR);
A61P37/04 (EP,KR);
C12N15/11 (KR);
C12N15/113 (EP,KR);
C12N15/85 (EP);
| C-Set: |
C12N2310/321, C12N2310/3525 (EP);
C12N2310/322, C12N2310/3533 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2025/13] | Title | German: | ANTITUMORMITTEL MIT RNA UND VERWENDUNG DAVON | [2025/13] | English: | ANTI-TUMOR AGENT CONTAINING RNA, AND USE THEREOF | [2025/13] | French: | AGENT ANTITUMORAL CONTENANT DE L'ARN ET UTILISATION ASSOCIÉE | [2025/13] | Entry into regional phase | 17.12.2024 | Translation filed | 17.12.2024 | National basic fee paid | 17.12.2024 | Search fee paid | 17.12.2024 | Designation fee(s) paid | 17.12.2024 | Examination fee paid | Examination procedure | 17.12.2024 | Amendment by applicant (claims and/or description) | 17.12.2024 | Examination requested [2025/13] | Fees paid | Renewal fee | 29.05.2025 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y] JP2021195364 (UNIV SHINSHU et al.) [Y] 1-16 * claims, paragraphs [0007], [0022], [0025], examples * | [XE] JP2023088734 (UNIV SHINSHU et al.) [XE] 1-16 * claims * | [Y] KOIZUMI KANA; MAEDA YUSUKE; KANO TOSHIFUMI; YOSHIDA HISAE; SAKAMOTO TAIICHI; YAMAGISHI KENJI; UENO YOSHIHITO: "Synthesis of 4′-C-aminoalkyl-2′-O-methyl modified RNA and their biological properties", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 12, 17 May 2018 (2018-05-17), AMSTERDAM, NL, pages 3521 - 3534, XP085408703, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2018.05.025 [Y] 1-16 * abstract * DOI: http://dx.doi.org/10.1016/j.bmc.2018.05.025 | [Y] KANO TOSHIFUMI; KATSURAGI YUI; MAEDA YUSUKE; UENO YOSHIHITO: "Synthesis and properties of 4-C-aminoalkyl-2-fluoro-modified RNA oligomers", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 15, 2 August 2018 (2018-08-02), AMSTERDAM, NL, pages 4574 - 4582, XP085463640, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2018.08.001 [Y] 1-16 * abstract * DOI: http://dx.doi.org/10.1016/j.bmc.2018.08.001 | [A] TOMITA TAKESHI, KATO MASAYOSHI, MISHIMA TAISHI, MATSUNAGA YUTA, SANJO HIDEKI, ITO KEN-ICHI, MINAGAWA KENTARO, MATSUI TOSHIMITSU, O: "Extracellular mRNA transported to the nucleus exerts translation-independent function", NATURE COMMUNICATIONS, NATURE PUBLISHING GROUP, UK, vol. 12, no. 1, 16 June 2021 (2021-06-16), UK, pages 3655, XP093108170, ISSN: 2041-1723, DOI: 10.1038/s41467-021-23969-1 [A] 1-16 * abstract * DOI: http://dx.doi.org/10.1038/s41467-021-23969-1 | by applicant | WO2018110678 | WO2019088179 | JP2019010035 | EMBO MOL MED, 2018, pages 10 | NAT COMMUN, vol. 4, 2013, pages 1853 [A] 1-16 * abstract * | CANCER RES, vol. 67, 2007, pages 93 - 99 | BR J HAEMATOL, vol. 139, 2007, pages 161 - 163 |